Wezi Sendama
banner
wezisendama.bsky.social
Wezi Sendama
@wezisendama.bsky.social
Lung doc @ Newcastle Hospitals; postdoc @ Newcastle University
Incredibly pleased to have been awarded a BIOREME Starter Grant! I'll be visiting the Statistical Biophysics lab at École Normale Supérieure in Paris to learn about probabilistic modelling of T cell receptor generation. I'll also be visiting as many local patisseries as possible.
February 4, 2025 at 10:09 AM
Skimmed this and looks an incredible piece of work. Looking forward to digging into it a little more. Nicely done!
Our massive effort to recontextualize #single #T-cell data is now out in Science Advances! We developed a new system, STEGO, to do a TCR-first analysis, and reanalyzed 12 studies and more than 500 000 individual T-cells.
Supported by @cziscience.bsky.social !
doi.org/10.1126/scia...
T cell receptor–centric perspective to multimodal single-cell data analysis
T cell receptor–centric perspective improves single-cell analysis.
doi.org
December 3, 2024 at 9:26 AM
Even if the trial is negative, the real primary outcome was the friends you made along the way
November 30, 2024 at 11:10 PM
Hopping into a canoe and paddling up the train tracks to Westminster for the BTS Winter Meeting
November 27, 2024 at 7:45 AM
Reposted by Wezi Sendama
T cell receptor sharing in hypersensitivity pneumonitis https://www.biorxiv.org/content/10.1101/2024.11.13.623392v1
T cell receptor sharing in hypersensitivity pneumonitis https://www.biorxiv.org/content/10.1101/2024.11.13.623392v1
Hypersensitivity pneumonitis (HP) is characterised by an excessive pulmonary T cell response in susc
www.biorxiv.org
November 16, 2024 at 5:15 AM
New preprint! We think it's possible to use TCR repertoire profiling to identify antigens in hypersensitivity pneumonitis. If two individuals with HP share disease-related TCRs, knowing one patient's HP antigen means you also know the other's.
www.biorxiv.org/content/10.1...
T cell receptor sharing in hypersensitivity pneumonitis
Hypersensitivity pneumonitis (HP) is characterised by an excessive pulmonary T cell response in susceptible individuals after exposure to inhaled antigens. The most effective treatment for the conditi...
www.biorxiv.org
November 16, 2024 at 10:35 PM
Back on here, I think. As good a time as any to mention that I'm giving a talk on ageing and pulmonary inflammation at the BTS Winter Conference in a couple of weeks... Maybe need to make the slides at some point
November 8, 2024 at 7:53 PM
Editor-in-Training at the Blue Journal? Don't mind if I do
December 20, 2023 at 4:41 PM
I don't think it's right to have a grant application window that opens in late November and closes at the end of January
November 19, 2023 at 12:15 PM
Fewer than 24 hours until I have a chance to walk into a big building and make a fool of myself in front of some very important people
October 16, 2023 at 4:21 PM
I have only ever met one person who has been able to convince me that they understand the kidney
October 3, 2023 at 11:10 AM
Editor-in-chief sending me more manuscripts to send out for review when I'm already fighting for my life trying to find reviewers for the ones I had before
September 28, 2023 at 5:33 PM
I would struggle to do this now with ggplot2
Florence Nightingale made this plot in 1858 *by hand*

Statistics was in its infancy, if it was even a field at all (at the time, Karl Pearson was a 1 year old, & the normal distribution had only been around for a few years)

en.wikipedia.org/wiki/Florenc...

She's one of the big heroes in stats
September 22, 2023 at 5:12 AM
Only just skimmed this today but looks a phenomenal paper: gain-of-function mutation identified in a muscle hypertrophy syndrome, reproduced in a mouse model, treated in mice with inhibitor, then treated in patients successfully. Looking forward to reading properly.

rupress.org/jem/article-...
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds ...
In this study, we have discovered that hemifacial myohyperplasia results from a somatic gain-of-function mutation in PI3KCA. Using a new mouse model, we investi
rupress.org
September 18, 2023 at 7:03 PM
I'm Wezi, a doctor specialising in respiratory medicine in Newcastle with a clinical interest in interstitial lung diseases. I'm also a postdoc at Newcastle University, and I have research interests in the innate and adaptive immune responses of the lung to antigen inhalation. #HiSciSky
September 18, 2023 at 6:56 PM
Great #PCCM MDT today. Haematologists and clinical immunologists brought along some cases of theirs to discuss: patients developing interstitial lung abnormalities secondary to CVID or after bone marrow transplant. Challenging cases, huge opportunity to learn how to do the best for these patients.
September 14, 2023 at 8:53 PM
Late to the party, but the Jupyter extension for VS Code is a sanity-saver
September 13, 2023 at 1:50 PM
Getting a feel for how Bluesky works while I hamfistedly work through some data processing, extracting T cell receptor sequences from publicly available scRNAseq datasets. Sounds boring but potentially very interesting if I can prove a hypothesis I have...
September 13, 2023 at 7:33 AM